Table 1

Distributions of live-attenuated influenza vaccine (LAIV) recipients’ characteristics as a function of lot documentation

2013–2014 season2014–2015 season
Documented lot
(n=47 396)
Missing lot
(n=21 101)
Documented lot
(n=67 099)
Missing lot
(n=19 134)
Time of administration
 September5%(2211)4%(848)1%(534)<1%(44)
 October46%(21 947)53%(11 226)43%(29 087)40%(7656)
 November36%(16 844)34%(7196)38%(25 217)41%(7787)
 December11%(5211)7%(1557)15%(10 206)17%(3220)
 January2%(1136)1%(251)3%(1697)2%(331)
 February<1%(38)<1%(18)1%(353)<1%(83)
 March<1%(9)<1%(5)<1%(5)<1%(13)
Age (years)
 2–476%(35 813)57%(12 061)69%(46 070)28%(5371)
 5–810%(4686)17%(3647)13%(8753)39%(7382)
 9–1714%(6897)26%(5393)18%(12 276)33%(6381)
Gender
 Female47%(22 510)48%(10 221)48%(31 934)49%(9351)
 Male53%(24 886)52%(10 880)52%(35 165)51%(9783)
Length of registration at practice
 <1 year10%(4547)15%(3219)9%(5874)9%(1789)
 ≥1 year90%(42 849)85%(17 882)91%(61 225)91%(17 345)
Region
 North16%(7355)20%(4303)12%(8368)8%(1558)
 England/Midlands14%(6467)10%(2023)17%(11 196)11%(2200)
 England/South29%(13 913)19%(4022)9%(5868)4%(827)
 England/London13%(6291)13%(2658)5%(3358)1%(97)
 Northern Ireland7%(3123)5%(1044)15%(10 239)60%(11 409)
 Scotland11%(5290)27%(5701)11%(7145)3%(624)
 Wales10%(4957)6%(1350)31%(20 925)13%(2419)
 North16%(7355)20%(4303)12%(8368)8%(1558)
Number of LAIV recipients by practice
 Lower than per-practice median*24%(11 220)19%(3951)25%(16 804)12%(2354)
 Per-practice median or higher76%(36 176)81%(17 150)75%(50 295)88%(16 780)
  • *The median numbers of LAIV recipients by practice were 107 and 152 in influenza seasons 2013–2014 and 2014–2015, respectively.